摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(1-methyl-1-phenyl-ethylcarbamoyl)-3-{4-(4-methyl-piperazin-1-yl)-2-[(tetrahydro-pyran-4-carbonyl)-amino]-benzoylamino}-thieno[2,3-c]pyrazole-1-carboxylic acid ethyl ester | 921768-29-8

中文名称
——
中文别名
——
英文名称
5-(1-methyl-1-phenyl-ethylcarbamoyl)-3-{4-(4-methyl-piperazin-1-yl)-2-[(tetrahydro-pyran-4-carbonyl)-amino]-benzoylamino}-thieno[2,3-c]pyrazole-1-carboxylic acid ethyl ester
英文别名
Ethyl 3-[[4-(4-methylpiperazin-1-yl)-2-(oxane-4-carbonylamino)benzoyl]amino]-5-(2-phenylpropan-2-ylcarbamoyl)thieno[2,3-c]pyrazole-1-carboxylate
5-(1-methyl-1-phenyl-ethylcarbamoyl)-3-{4-(4-methyl-piperazin-1-yl)-2-[(tetrahydro-pyran-4-carbonyl)-amino]-benzoylamino}-thieno[2,3-c]pyrazole-1-carboxylic acid ethyl ester化学式
CAS
921768-29-8
化学式
C36H43N7O6S
mdl
——
分子量
701.847
InChiKey
VFLUCAYVHPXWQR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    50
  • 可旋转键数:
    10
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    175
  • 氢给体数:
    3
  • 氢受体数:
    10

文献信息

  • 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors
    申请人:Fancelli Daniele
    公开号:US20090149457A1
    公开(公告)日:2009-06-11
    There are provided thieno[2,3-c]pyrazole derivatives of formula (I), wherein A is an aryl or heteroaryl ring, on which the substituent-NHZR 5 is at the ortho position to the CONH linker; R 1 and R 2 are the same or different and, independently from each other, represent a hydrogen atom or an organic group; R 4 is a hydrogen or halogen atom or an organic group; Z is direct bond, >C═O, or —C(═O)NH—; R 5 is hydrogen or an organic group; or isomers, tautomers, carriers, metabolites, prodrugs, and pharamaceutically acceptable salts thereof. A process for their preparation and pharamaceutical compositions comprising them are also disclosed; the compounds of the invention may be useful, in theraphy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    提供了式(I)的噻吩[2,3-c]吡唑生物,其中A是芳基或杂环芳基环,其上取代基-NHZR5位于CONH连接基的邻位;R1和R2相同或不同且独立地表示氢原子或有机基团;R4是氢原子或卤素原子或有机基团;Z是直接键,>C═O或—C(═O)NH—;R5是氢原子或有机基团;或其异构体,互变异构体,载体,代谢产物,前药和药物学上可接受的盐。还公开了它们的制备方法和包含它们的药物组合物;该发明的化合物在治疗与蛋白激酶活性失调相关的疾病,如癌症方面可能有用。
  • 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS
    申请人:NERVIANO MEDICAL SCIENCES S.R.L.
    公开号:EP1904503B1
    公开(公告)日:2013-11-06
  • US7943654B2
    申请人:——
    公开号:US7943654B2
    公开(公告)日:2011-05-17
  • [EN] 1H-THIENO[2,3-C]PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSES 1H-THIENO[2,3-C]PYRAZOLE SERVANT D'INHIBITEURS DE KINASE
    申请人:NERVIANO MEDICAL SCIENCES SRL
    公开号:WO2007009898A1
    公开(公告)日:2007-01-25
    [EN] There are provided thieno[2,3-c]pyrazole derivatives of formula (I), wherein A is an aryl or heteroaryl ring, on which the substituent -NHZR5 is at the ortho position to the CONH linker; R1 and R2 are the same or different and, independently from each other, represent a hydrogen atom or an organic group; R4 is a hydrogen or halogen atom or an organic group; Z is direct bond, >C=O, or -C(=O)NH-; R5 is hydrogen or an organic group; or isomers, tautomers, carriers, metabolites, prodrugs, and pharmaceutically acceptable salts thereof. A process for their preparation and pharmaceutical compositions comprising them are also disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    [FR] L'invention concerne des dérivés de thiéno[2,3-c]pyrazole de formule (I). Dans cette formule, A désigne un anneau aryle ou hétéroaryle sur lequel le substituant -NHZR5 est situé à l'ortho-position correspondant au liant CONH; R1 et R2 sont identiques ou différents et, indépendamment l'un de l'autre, désignent un atome d'hydrogène ou un groupe organique; R4 désigne un atome d'hydrogène ou d'halogène ou un groupe organique; Z désigne une liaison directe, >C=O, ou -C(=O)NH-; R5 désigne hydrogène ou un groupe organique; ou des isomères, des tautomères, des vecteurs, des métabolites, des promédicaments et des sels pharmaceutiquement acceptables de ceux-ci. L'invention concerne un procédé pour la préparation de ces dérivés et des compositions pharmaceutiques les comprenant. Les composés de l'invention peuvent être utiles dans une thérapie, dans le traitement de maladies associées à une activité dérégulée de protéines kinases, notamment le cancer.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)